Taltz Results In Spondyloarthritis Add To Lilly Franchise Hopes

 
• By Jo Shorthouse
Yacht
Seemingly plain sailing for ixelizumab in non-radiographic axial spondyloarthritis trial • Source: Shutterstock

More from Clinical Trials

More from R&D